Improving HIV prevention and care for adolescents and young adults in Uganda
Official title: Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Adolescent and Youth HIV Prevention and Care Continuums in Rural and Urban Uganda
Funded at Mu-Jhu Care · NIH-11395127 · Data updated 2026-11-12
This project offers new ways to deliver long-acting HIV prevention and stronger treatment support for adolescents and young adults (ages 15–24) in Uganda.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mu-Jhu Care NIH-funded |
| Lab location | 1 site (Kampala, Uganda) |
| Project start | September 8, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $200,464 |
| NIH project number | 3UG1HD113241-03S1 |
| Project ID | NIH-11395127 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adolescents and young adults aged 15–24 who are at high risk for HIV or who are living with HIV and receive care at participating clinics or community sites in Uganda.
✕Less likely to help
People younger than 15, older than 24, or those who cannot access the participating sites in Uganda are unlikely to be eligible or directly benefit from this project.
What this research studies
If you join, you may be offered long-acting injectable HIV prevention (cabotegravir) or support services tailored to youth to help you start and stay on prevention or treatment. The project uses new risk screening methods and community-friendly delivery options so services can be provided at clinics or in community settings rather than only at hospitals. For young people living with HIV, a multi-component package called SEARCH-Youth provides life-stage based assessment and support to help reach and keep viral suppression. The study runs in both rural and urban areas of Uganda and combines practical delivery tests with measures of health outcomes to see what works in real-world care.
Why it matters
Potential benefit: If successful, this work could make it easier for young people in Uganda to avoid HIV with long-acting prevention and to achieve and maintain viral suppression if they have HIV.
How similar studies have gone: Large clinical trials have shown long-acting cabotegravir can prevent HIV, and youth-focused delivery models show promise, but combining these approaches in routine Ugandan settings is relatively new.
Where this research is happening
-
Mu-Jhu Care
Kampala, Uganda Active
Researchers
- Principal investigator: Musoke, Philippa — Mu-Jhu Care
- Study coordinator: Musoke, Philippa
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Improving HIV Prevention and Care for Ugandan Adolescents and Young Adults
A Uganda-based research effort aims to boost HIV prevention and care outcomes for 15-24 year-olds by testing practical, community-based strategies to increase PrEP use and viral suppression.
-
Adolescent and Youth HIV Prevention and Care Improvements in Uganda
A UG1 grant is testing ways to help Ugandan teens and young adults (ages 15-24) prevent HIV and stay healthy if they have HIV, using new long-acting PrEP and community care approaches.
-
Malkia Klabu: safer, youth-friendly pharmacies to boost HIV prevention for AGYW in Tanzania
A Tanzania-based project tests a youth-friendly pharmacy model to improve access to HIV prevention and sexual health services for adolescent girls and young women.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan study tests new ways to help teens and young adults (ages 15–24) prevent HIV and stay healthy if they are living with HIV, using community-based options and long-acting PrEP.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.